View of Ameliorating COVID-19-related Acute respiratory distress syndrome (ARDS) with the multi-target strategy utilising natural supplements-from in-silico to a randomised controlled clinical trial

Return to Article Details Ameliorating COVID-19-related Acute respiratory distress syndrome (ARDS) with the multi-target strategy utilising natural supplements-from in-silico to a randomised controlled clinical trial Download Download PDF